ITC Section 337 Investigations: Response to Complaint | Practical Law

ITC Section 337 Investigations: Response to Complaint | Practical Law

A Standard Document that an accused infringer may use as a starting point for drafting a response to a patent infringement complaint at the US International Trade Commission (ITC) under Section 337 of the Tariff Act of 1930 (19 U.S.C. § 1337) and ITC Rule 210.13 (19 C.F.R. § 210.13). This Standard Document contains integrated drafting notes with important explanations and tips for drafting the response to the complaint and notice of investigation, asserting defenses commonly raised by respondents, and preparing the statistical information on the accused products required by ITC Rule 210.13 (19 C.F.R. § 210.13).

ITC Section 337 Investigations: Response to Complaint

Practical Law Standard Document w-018-7474 (Approx. 30 pages)

ITC Section 337 Investigations: Response to Complaint

by Practical Law Intellectual Property & Technology
Maintained • USA (National/Federal)
A Standard Document that an accused infringer may use as a starting point for drafting a response to a patent infringement complaint at the US International Trade Commission (ITC) under Section 337 of the Tariff Act of 1930 (19 U.S.C. § 1337) and ITC Rule 210.13 (19 C.F.R. § 210.13). This Standard Document contains integrated drafting notes with important explanations and tips for drafting the response to the complaint and notice of investigation, asserting defenses commonly raised by respondents, and preparing the statistical information on the accused products required by ITC Rule 210.13 (19 C.F.R. § 210.13).
In response to the COVID-19 outbreak, the ITC waived all paper and other physical media filing requirements, amended other rules to implement electronic document service, and authorized remote hearings at the presiding ALJ's discretion. For more information, see Temporary Change to Filing Procedures, 85 Fed. Reg. 15798 (Mar. 19, 2020) (Notice) and USITC: Frequently Asked Questions: Section 337 Investigations – COVID-19-Related Questions.